Revenue
$54.0M
▲ 48.0% YoY
Net Income
-$412.8M
▼ 161.3% YoY
EPS
$-7.12
▼ 161.2% YoY
Cash
$89.1M
▲ 16.9% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Gheuens Sarah Chief Medical Officer | Sell | Aug 4, 2026 | 30.0K | $30.48 | $914K | Form 4 ↗ |
Backstrom Jay T. Director | Grant | Jul 8, 2026 | 1.4K | $0.00 | $0 | Form 4 ↗ |
Gheuens Sarah Chief Medical Officer | Vest | Jul 1, 2026 | 8.4K | $0.00 | $0 | Form 4 ↗ |
Gheuens Sarah Chief Medical Officer | Sell | Jul 1, 2026 | 4.0K | $37.56 | $151K | Form 4 ↗ |
Scadden David Director | Vest | Jun 18, 2026 | 2.8K | $0.00 | $0 | Form 4 ↗ |